Preventing Excessive Gestational Weight Gain Via Short Mobile Messages in WIC
Sponsor
University of Hawaii (Other)
Overall Status
Completed
CT.gov ID
NCT04330976
Collaborator
(none)
83
1
2
19.1
4.4
Study Details
Study Description
Brief Summary
The objective of this trial was to investigate the effect of educational short message service (SMS), or text messages, on gestational weight gain (GWG) in a low-income population.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
83 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Care Provider)
Primary Purpose:
Prevention
Official Title:
Preventing Excessive Gestational Weight Gain Via Short Mobile Messages in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC)
Actual Study Start Date
:
Oct 30, 2017
Actual Primary Completion Date
:
Oct 29, 2018
Actual Study Completion Date
:
Jun 2, 2019
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Nutrition and physical activity intervention
|
Behavioral: Nutrition and physical activity intervention
Messages sent on nutrition and physical activity in pregnancy
|
Other: Control
|
Behavioral: Control
Messages sent on general health during pregnancy
|
Outcome Measures
Primary Outcome Measures
- Change between pre-pregnancy weight and last weight taken before delivery [From date of randomization until delivery of child (e.g. up to 25 weeks)]
Total weight gained during pregnancy
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
15-20 weeks gestational age and 18 years of age or older at time of recruitment
-
body mass index (BMI) of 25-45 kg/m2 in the first trimester
-
possession of a cellular phone with the ability to receive text messages without a charge
Exclusion Criteria:
-
conditions requiring a special diet
-
multiparous pregnancies
-
unable to consent to participate
-
unwilling to be randomized
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Hawaii | Honolulu | Hawaii | United States | 96822 |
Sponsors and Collaborators
- University of Hawaii
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University of Hawaii
ClinicalTrials.gov Identifier:
NCT04330976
Other Study ID Numbers:
- 5U54MD008149-09
First Posted:
Apr 2, 2020
Last Update Posted:
Apr 2, 2020
Last Verified:
Mar 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: